These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2875588

  • 1. Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.
    Morita S, Izumi M, Nagataki S.
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):517-22. PubMed ID: 2875588
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N, Izumi M, Katamine S, Nagataki S.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [Abstract] [Full Text] [Related]

  • 3. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y, Takamatsu J, Sakane S, Hirai K, Kuma K, Ohsawa N.
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [Abstract] [Full Text] [Related]

  • 4. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
    Macchia E, Concetti R, Borgoni F, Cetani F, Fenzi GF, Pinchera A.
    Autoimmunity; 1989 Aug; 3(2):103-12. PubMed ID: 2577491
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C, Vitti P, Lopez G, Santini F, Mammoli C, Fenzi GF, Pinchera A.
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: correlation with thyrotropin binding-inhibiting antibodies.
    Hensen J, Kotulla P, Finke R, Bogner U, Badenhoop K, Meinhold H, Schleusener H.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):980-7. PubMed ID: 6144692
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
    Takasu N, Yamashiro K, Ochi Y, Sato Y, Nagata A, Komiya I, Yoshimura H.
    Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
    [Abstract] [Full Text] [Related]

  • 15. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 16. The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.
    Bliddal H, Hegedüs L, Hansen JM, Bech K, van der Gaag R, Drexhage HA.
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):75-84. PubMed ID: 2888551
    [Abstract] [Full Text] [Related]

  • 17. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
    Macchia E, Fenzi GF, Monzani F, Lippi F, Vitti P, Grasso L, Bartalena L, Baschieri L, Pinchera A.
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
    [Abstract] [Full Text] [Related]

  • 18. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
    Inui T, Kouki T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Sato Y, Nagata A.
    Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
    [Abstract] [Full Text] [Related]

  • 19. TSH binding-inhibiting antibodies in hyperthyroidism: relationship to clinical signs and hormone levels.
    Benker G, Kotulla P, Kendall-Taylor P, Emrich D, Reinwein D.
    Clin Endocrinol (Oxf); 1989 Jan; 30(1):19-28. PubMed ID: 2570653
    [Abstract] [Full Text] [Related]

  • 20. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.